Asia-Pacific is moving from being viewed primarily as a later-stage commercial market to becoming a more important sourc...
Adneuris Therapeutics, a wholly owned subsidiary of Tris Pharma advancing a new kind of pain medicine, has entered ...
Innovent Biologics, Inc. and Daiichi Sankyo have entered into an exclusive agreement for the commercialisation of Vanfly...
Bristol Myers Squibb (BMS) has announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-...
Japan-based Chugai Pharmaceutical and the University of California, San Francisco (UCSF) have entere...
Merck, a leading science and technology company, is expanding its Singapore lab to further strengthen analytical and bio...
BIOSPECTRUM ASIA | EARNINGS ALERTS +35.2% 10.7 pt -15% EUR 0.15 Celltrion r...
Northwest Biotherapeutics, a US-based biotechnology company developing DCVax® personalised immune therapies for soli...
Energenesis Biomedical has entered into a joint development agreement with Taiwan Tanabe Seiyaku, the wholly owned ...
Alteogen Inc., a South Korea-based biopharmaceutical company specialising in platform technologies, has entered into an ...
The US Food and Drug Administration has approved Moderna’s mFlusiva seasonal influenza vaccine for adults aged 50 ...
Counterfeit and unauthorised healthcare products remain a persistent risk across Asia, particularly where fragmented dis...
Antengene has received a $60 million upfront payment from UCB under a worldwide exclusive licensing agreement for ATG-20...
Kelun-Biotech has received approval from the Center for Drug Evaluation of China’s National Medical Products Admin...
How would you assess the current state of Thailand's life sciences ecosystem, and what key developments have stood out o...
Bispecific antibodies have transformed treatment by simultaneously targeting two molecules, delivering significant clini...
Although each rare disease affects only a small number of people, collectively they represent one of the world's largest...
Ember LifeSciences, Inc. has entered into a capital and business alliance with Alfresa Corporation, a subsidiary of Alfr...
AbbVie has announced the availability of ELAHERE® (mirvetuximab soravtansine) in Singapore for the treatment of plat...
Japan-based Ono Pharmaceutical and US-based Phylo, Inc. have announced a collaboration that brings Biomni Lab, Phylo's a...
DKSH Business Unit Healthcare, a strategic healthcare solutions partner and leading provider of Market Expansion Service...
Asia's biopharmaceutical manufacturing sector is entering a new phase of growth, driven by expanding biologics pipelines...
Nippon Kayaku and Celltrion Healthcare Japan K.K. have entered into a Memorandum of Understanding (MoU) on Compreh...
Takeda China has announced that the National Medical Products Administration (NMPA) has approved the use of ORZEYFUL (ov...
It is estimated that by 2040 China-originated treatments will represent 35% of US FDA approvals. When marketing treatmen...
